Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with...
Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication
Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...
Medical Information in the Digital Age – Quick and Efficient Meets Responsive and Responsible
Medical Information (MI teams across the pharmaceutical industry respond to product-related medical queries from HCPs...
Plain Language in Plain Sight: Why Making It Easier for Patients to Access Content They Understand Pays Off
With so many different types of Plain Language Summaries, and the interchangeable terms used for...
The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents
Better patient awareness has led to a rapid increase in the number of MI requests...